Gainers
- Nymox Drug NYMX supply climbed 30.0% to $0.42 throughout Friday’s after-market session. The firm’s market cap stands at $38.4 million.
- Renalytix RNLX shares relocated up-wards by 11.63% to $2.59. The firm’s market cap stands at $121.2 million.
- Trxade Wellness MEDICATIONS shares enhanced by 10.86% to $0.38. The firm’s market cap stands at $3.5 million.
- Bionomics BNOX supply relocated up-wards by 9.91% to $3.77. The firm’s market cap stands at $30.7 million.
- NRX Pharmaceuticals NRXP supply enhanced by 8.93% to $0.73. The marketplace worth of their superior shares goes to $49.4 million.
- Gelesis Holdings GLS supply relocated up-wards by 8.33% to $0.26. The firm’s market cap stands at $19.0 million.
Losers
- Infinity Pharmaceuticals INFI supply lowered by 7.6% to $0.18 throughout Friday’s after-market session. The firm’s market cap stands at $16.1 million.
- EUDA Wellness Holdings EUDA shares lowered by 7.43% to $1.87. Today’s trading quantity for this safety wound up closing at 66.4 K shares, which is 50.5 percent of its typical quantity over the last 100 days. The marketplace worth of their superior shares goes to $41.8 million.
- Sunlight Biopharma SBFM supply decreased by 7.24% to $0.79. The firm’s market cap stands at $17.8 million.
- Gritstone Biography GRTS supply lowered by 6.11% to $2.0. The firm’s market cap stands at $166.7 million. Based on journalism launch, Q4 profits appeared the other day.
- MorphoSys MOR supply dropped 5.81% to $3.57. The firm’s market cap stands at $487.8 million.
- Benitec Biopharma BNTC supply lowered by 5.41% to $0.24. The firm’s market cap stands at $6.8 million.
See Additionally: www.benzinga.com/money/best-healthcare-stocks/
This write-up was produced by Benzinga’s computerized material engine and also assessed by an editor.
© 2023 Benzinga.com. Benzinga does not give financial investment recommendations. All legal rights booked.
